| Literature DB >> 34603686 |
Takahiro Sato1, Bharath Ambale-Venkatesh2, Stefan L Zimmerman2, Ryan J Tedford3, Steven Hsu4, Ela Chamera4, Tomoki Fujii4, Christopher J Mullin5, Valentina Mercurio1, Rubina Khair1, Celia P Corona-Villalobos2, Catherine E Simpson1, Rachel L Damico1, Todd M Kolb1, Stephen C Mathai1, Joao A C Lima4, David A Kass4, Ichizo Tsujino6, Paul M Hassoun1.
Abstract
Right ventricular function has prognostic significance in patients with pulmonary hypertension. We evaluated whether cardiac magnetic resonance-derived strain and strain rate parameters could reliably reflect right ventricular systolic and diastolic function in precapillary pulmonary hypertension. End-systolic elastance and the time constant of right ventricular relaxation tau, both derived from invasive high-fidelity micromanometer catheter measurements, were used as gold standards for assessing systolic and diastolic right ventricular function, respectively. Nineteen consecutive precapillary pulmonary hypertension patients underwent cardiac magnetic resonance and right heart catheterization prospectively. Cardiac magnetic resonance data were compared with those of 19 control subjects. In pulmonary hypertension patients, associations between strain- and strain rate-related parameters and invasive hemodynamic parameters were evaluated. Longitudinal peak systolic strain, strain rate, and early diastolic strain rate were lower in PAH patients than in controls; peak atrial-diastolic strain rate was higher in pulmonary hypertension patients. Similarly, circumferential peak systolic strain rate was lower and peak atrial-diastolic strain rate was higher in pulmonary hypertension. In pulmonary hypertension, no correlations existed between cardiac magnetic resonance-derived and hemodynamically derived measures of systolic right ventricular function. Regarding diastolic parameters, tau was significantly correlated with peak longitudinal atrial-diastolic strain rate (r = -0.61), deceleration time (r = 0.75), longitudinal systolic to diastolic time ratio (r = 0.59), early diastolic strain rate (r = -0.5), circumferential peak atrial-diastolic strain rate (r = -0.52), and deceleration time (r = 0.62). Strain analysis of the right ventricular diastolic phase is a reliable non-invasive method for detecting right ventricular diastolic dysfunction in PAH.Entities:
Keywords: pressure volume loop; pulmonary arterial hypertension; right ventricular failure; strain and strain rate; tau
Year: 2021 PMID: 34603686 PMCID: PMC8481729 DOI: 10.1177/20458940211032529
Source DB: PubMed Journal: Pulm Circ ISSN: 2045-8932 Impact factor: 2.886
Fig. 1.(a) Representative image of right ventricular (RV) longitudinal peak systolic strain and peak strain rate in the 4-chamber view. (b) Representative image of RV circumferential peak strain and strain rate measurement in the short axis view at the mid-level. RV and left ventricular free wall were traced as a whole after the confirmation of six segments. Thereafter, three left ventricular free wall segments were excluded. (c) Representative strain curve image of control subjects. (d) Representative strain curve image of patients with pulmonary arterial hypertension. Peak systolic strain, systolic time, and diastolic time were identified from the strain curve. (e) Representative strain rate curve image of control subjects. (f) Representative strain rate image of image of patients with pulmonary arterial hypertension. Peak systolic strain rate, peak early diastolic strain rate (SRe), peak atrial-diastolic strain rate, and deceleration time of SRe were also analyzed from the strain rate curve.
Demographics of participants.
| Parameters | Controls ( | Patients with PH ( | |
|---|---|---|---|
| Age (years) | 57 ± 5 | 56 ± 13 | 0.644 |
| Sex (male/female) | 3/16 | 3/16 | 1.00 |
| Body surface area (m2) | 1.81 ± 0.18 | 1.82 ± 0.21 | 0.82 |
| Race (white/non-white) | 11/8 | 16/3 | 0.0625 |
| Systolic systemic blood pressure (mmHg) | 119 ± 19 | 125 ± 19 | 0.3261 |
| Diastolic systemic blood pressure (mmHg) | 71 ± 10 | 71 ±10 | 0.8263 |
| Hypertension (n) | 1 | 3 | 0.6039 |
| Hyperlipidemia (n) | 1 | 3 | 0.6039 |
| Diabetes mellitus (n) | 2 | 1 | 1.000 |
| Right ventricular measurements | |||
| End-diastolic volume (ml) | 105 ± 20 | 171 ± 57 | <0.0001 |
| End-systolic volume (ml) | 45 ± 11 | 95 ± 39 | <0.0001 |
| Mass (g) | 20 ± 4 | 27 ± 8 | 0.003 |
| Ejection fraction (%) | 57 ± 5 | 45 ± 9 | <0.0001 |
| Left ventricular measurements | |||
| End-diastolic volume (ml) | 130 ± 25 | 114 ± 25 | 0.0641 |
| End-systolic volume (ml) | 52 ± 16 | 46 ± 11 | 0.1616 |
| Mass index (g) | 116 ± 23 | 82 ± 18 | <0.0001 |
| Ejection fraction (%) | 60 ± 8 | 60 ± 6 | 0.9257 |
| Right ventricular strain measurements | |||
| Longitudinal peak systolic strain (%) | −31 ± 4.6 | −24.5 ± 6.4 | 0.0001 |
| Longitudinal peak systolic strain rate (m/s) | −1.42 ± 0.22 | −1.09 ± 0.29 | 0.0003 |
| Longitudinal early diastolic strain rate (m/s) | 2.12 ± 0.66 | 0.74 ± 0.37 | <0.0001 |
| Longitudinal peak atrial-diastolic strain rate (m/s) | 0.69 ± 0.44 | 1.5 ± 1.13 | 0.0382 |
| Longitudinal deceleration time of early diastolic strain rate (ms) | 193 (138–233) | 119 ± 29 | <0.001 |
| Longitudinal R-R interval (ms) | 921 ± 124 | 846 ± 145 | 0.954 |
| Longitudinal systolic time (ms) | 345 ± 34 | 371 ± 63 | 0.1196 |
| Longitudinal diastolic time (ms) | 576 ± 114 | 475 ± 86 | 0.0038 |
| Longitudinal systolic to diastolic duration ratio | 0.62 ± 0.14 | 0.78 ± 0.1 | <0.0001 |
| Circumferential peak systolic strain (%) | −14 ± 2.8 | −12.2 ± 3.1 | 0.728 |
| Circumferential peak systolic strain rate (m/s) | −0.66 ± 0.17 | −0.48 ± 0.15 | 0.0045 |
| Circumferential early diastolic strain rate (m/s) | 0.77 ± 3 | 0.72 ± 0.34 | 0.587 |
| Circumferential peak atrial-diastolic strain rate (m/s) | 0.25 ± 0.08 | 0.31 (0.26–0.52) | 0.0078 |
| Circumferential deceleration time of early diastolic strain rate (ms) | 226 ± 59 | 169 ± 74 | 0.0135 |
| Circumferential R-R interval (ms) | 912 ± 117 | 833 ± 137 | 0.0655 |
| Circumferential systolic time (ms) | 350 ± 39 | 408 ± 65 | 0.0021 |
| Circumferential diastolic time (ms) | 562 ± 101 | 426 ± 98 | 0.0002 |
| Circumferential systolic to diastolic duration ratio | 0.64 ± 0.11 | 1.0 ± 0.2 | <0.0001 |
PH: pulmonary hypertension.
Characteristics of patients with pulmonary arterial hypertension.
| Diagnosis | |
| IPAH | 6 (32%) |
| SSc-PAH | 10 (53%) |
| SSc-ILD-PH | 3 (16%) |
| WHO-functional class | |
| I | 1 (5%) |
| II | 7 (37%) |
| III | 11 (58%) |
| Pulmonary hemodynamics | |
| Systolic pulmonary artery pressure (mmHg) | 53 (44–82) |
| Diastolic pulmonary artery pressure (mmHg) | 21 (16–30) |
| Mean pulmonary artery pressure (mmHg) | 33 (27–49) |
| Pulmonary capillary wedge pressure (mmHg) | 8 ± 3 |
| Right ventricular end-diastolic pressure (mmHg) | 7 (5–10) |
| Mean right atrial pressure (mmHg) | 5 (4–8) |
| Cardiac index (L/min/m2) | 2.4 ± 0.5 |
| Pulmonary vascular resistance (Wood Units) | 5.5 (4.5–9) |
| Use of pulmonary hypertension-specific vasodilators | |
| Prostanoid | 0 (0%) |
| PDE-5 inhibitor | 8 (42%) |
| Endothelin receptor antagonist | 4 (21%) |
| Calcium channel blocker | 7 (37%) |
| Diuretics | 10 (53%) |
| None | 5 (26%) |
| Brain natriuretic peptide (pg/ml) | 205 (130–526) |
|
| |
| RV afterload | |
| Effective arterial elastance (Ea) | 0.71 (0.65–1.11) |
| RV systolic function | |
| End-systolic elastance (Ees) | 0.62 (0.43–0.96) |
| RV-pulmonary arterial coupling | |
| Ees/Ea | 0.78 (0.45–1.04) |
| RV diastolic function | |
| Tau (ms) | 32.5 ± 11.3 |
IPAH: idiopathic PAH; SSc-PAH: scleroderma-associated PAH; SSc-ILD-PH: scleroderma with interstitial lung disease and PH; WHO: World Health Organization; PDE: phosphodiesterase; RV: right ventricular.
Fig. 2.Correlations between tau and cardiac magnetic resonance-derived strain and strain rate parameters. S:D: systolic to diastolic duration